Brain bleed breakthrough? new study tests antidote for blood thinner patients
NCT ID NCT05127941
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study observed 141 people in German stroke units who had a brain bleed while taking the blood thinners rivaroxaban or apixaban. Researchers wanted to see if giving the reversal drug andexanet alfa could stop the bleed from getting bigger. They tracked changes in bleed size on brain scans and checked patients' recovery and survival up to 90 days later.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL HEMORRHAGES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medizinische Hochschule Hannover
Hanover, 30625, Germany
-
Universitätsklinikum Tübingen
Tübingen, 72076, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple ear probe replace invasive brain pressure monitoring?
- Blood-Clotting showdown: which device best guides bleeding care in High-Risk patients?
- New rule could help emergency dispatchers spot hidden brain bleeds in elderly fall victims
- Stroke ambulance trial aims to cut disability from brain bleeds
- New drug injection aims to dissolve brain bleeds safely
- Brain bleed After-Effects study pulled before start